Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression
A single administration of COMP360 demonstrated a highly statistically significant and clinically meaningful reduction in symptom severity as measured by MADRS1... Read more.
Media Reminder: Grand Opening Celebration of Senior Housing in Gravette, Arkansas
***1:00 p.m., Tuesday, June 24, 501 Dallas Street SW, Gravette, Arkansas 72736*** GRAVETTE, Ark.–(BUSINESS WIRE)–#affordablehousing–Representatives... Read more.
Linde Signs Long-Term Agreement to Supply Industrial Gases to World-Scale Low-Carbon Ammonia Facility in Louisiana
WOKING, England–(BUSINESS WIRE)–Linde (Nasdaq: LIN) today announced it has signed a new long-term agreement with Blue Point Number One, a joint venture... Read more.
IFF Opens New State-of-the-art Office in Hyderabad, India
Newly constructed site reflects the Company’s commitment to scaling its global business services operations. HYDERABAD, India–(BUSINESS WIRE)–IFF (NYSE:... Read more.
Lead Bank Taps Prelim to Modernize Digital Onboarding for Consumers and Businesses
SAN FRANCISCO–(BUSINESS WIRE)–Prelim, a Silicon Valley-based fintech known for its award-winning omnichannel onboarding solutions, is now working with... Read more.
ICE First Look at Mortgage Performance: Delinquencies Held Steady in May but Continue to Trend Higher on an Annual Basis
ATLANTA & NEW YORK–(BUSINESS WIRE)–ICE Mortgage Technology, neutral provider of a robust end-to-end mortgage platform and part of Intercontinental... Read more.
Which VinFast EV Fits Your Life Best: VF 8 or VF 9?
MARKHAM, Ontario–(BUSINESS WIRE)–VinFast is drawing a line between lifestyles with its 2024 VF 8 and VF 9 Plus models, with one designed for agile,... Read more.
INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Apple Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – AAPL
SAN DIEGO–(BUSINESS WIRE)–Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Apple Inc. (NASDAQ: AAPL) securities between... Read more.
Ono Pharmaceutical and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea
Ono and Vertex have entered into an exclusive collaboration and license agreement for povetacicept in Japan and South Korea Povetacicept is a therapeutic in development... Read more.
Vertex and Ono Pharmaceutical Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea
– Exclusive collaboration and license agreement for povetacicept in these countries – – Ono will leverage its deep expertise in clinical development... Read more.